Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer
Clinical trial NCT00096083 · COMPLETED
Trial details
- NCT number
- NCT00096083
- Sponsor
- Delcath Systems Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2012-08-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.